Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 3c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q4 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $58.42 million versus the consensus estimate of $55.17 million.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c